Skip to Main Content

Paper Details

Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.
Brain
15
2022
AD, APOE, Alzheimer Disease, Alzheimer disease, Alzheimer's, Alzheimer's disease, Dementia, amyloid-?, cognitive impairment, p-tau181, participants
Author NameAffiliation
David M HoltzmanCharles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine in St Louis
David M HoltzmanWashington University School of Medicine in St Louis
John C MorrisCharles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine in St Louis
John C MorrisWashington University School of Medicine in St Louis
John C MorrisWashington University School of Medicine in St Louis
  • 1 - 5

Datasets

Release 1.2